The Collaborative Islet Transplantation Registry Program
Page 2

The program also seeks to deeply comprehend the factors that contribute to the success and/or failure of islet transplantation protocols and more importantly, to develop approaches for continued improvements that could essentially result in sustained graft function and therapeutic durability.

The National Institutes of Health and the National Institute of Diabetes and Digestive and Kidney Diseases are willing to administer funds in the amount $2,650,000 to support the initiatives of the program.

The institutions and organizations who will be considered eligible to participate in this program are the following:

a) State Governments

b) County Governments

c) City or Township Govenments

d) Special District Governments

e) Independent School Districts

f) Public and State Controlled Institutions of Higher Education

g) Native American Tribal Governments

h) Public Housing Authorities/Indian Housing Authorities

i) Native American Tribal Organizations (other than Federally recognized tribal governments)

j) Nonprofit Organizations

k) Private Institutions of Higher Education

l) For-profit organizations other than small businesses

m) Small Businesses

The United States Department of Health and Human Services, the mother agency funding the The Collaborative Islet Transplantation Registry Program, is the country's leading program that's constantly working towards protecting the health of all Americans and providing fundamental human services to all.

The Collaborative Islet Transplantation Registry Program
  Back to Page 1

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program
In this capacity, the Food and Drug Administration has recently established the Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program in an attempt to study the effects of various physicochemical properties of ophthalmic suspensions and emulsions on ocular bioavailability.

---

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---

Minority-Based Community Clinical Oncology Program Groups
In line with this mission, the National Institutes of Health has recently collaborated with the National Cancer Institute (NCI) in an attempt to establish the Minority-Based Community Clinical Oncology Program Groups (MBCCOP).

---

Critical Congenital Heart Disease Newborn Screening Demonstration Program
The Health Resources and Services Administration has recently constituted the Critical Congenital Heart Disease (CCHD) Newborn Screening Demonstration Program in order to support and encourage the development, dissemination, and validation of screening protocols and newborn screening infrastructure for point of care screenings that are specific to Critical Congenital Heart Diseases.

---